BFA
SLXP

BlackRock Fund Advisors’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

BlackRock Fund Advisors’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,755,863
Closed -$303M – 3995
2015
Q1 		$303M Sell
1,755,863
-1,002,063
-36% -$147M 0.07% 295
2014
Q4 		$317M Buy
2,757,926
+15,988
+0.6% +$1.94M 0.08% 261
2014
Q3 		$428M Buy
2,741,938
+68,732
+3% +$9.96M 0.12% 150
2014
Q2 		$330M Buy
2,673,206
+75,160
+3% +$8.31M 0.09% 201
2014
Q1 		$269M Sell
2,598,046
-13,720
-0.5% -$1.4M 0.08% 246
2013
Q4 		$235M Buy
2,611,766
+239,945
+10% +$19.1M 0.07% 288
2013
Q3 		$159M Buy
2,371,821
+3,360
+0.1% +$232K 0.05% 435
2013
Q2 		$157M Buy
+2,368,461
New +$135M 0.06% 384

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

BlackRock Fund Advisors's SLXP Position: Q2 2015 in Review

BlackRock Fund Advisors sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,755,863 shares — an estimated $303M sold.

BlackRock Fund Advisors first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $428M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • BlackRock Fund Advisors reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • BlackRock Fund Advisors sold 1,755,863 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $303M.
  • BlackRock Fund Advisors first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • BlackRock Fund Advisors's SALIX PHARMACEUTICALS LTD DEL position peaked at $428M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on BlackRock Fund Advisors's 13F filing for Q2 2015, filed 7 Aug 2015.